Integration of machine learning and pan-genomics expands the biosynthetic landscape of RiPP natural products
Authors:
- Alexander M. KloostermanAKAlexander M. Kloosterman
- Peter CimermancicPCPeter Cimermancic
- Somayah Sma ElsayedSESomayah Sma Elsayed
- Chao DuCDChao Du
- Michalis HadjithomasMHMichalis Hadjithomas
- Mohamed S. DoniaMDMohamed S. Donia
- Michael A. FischbachMFMichael A. Fischbach
- Gilles P. van WezelGWGilles P. van Wezel
- Marnix H. MedemaMMMarnix H. Medema
Preprint
Abstract
Most clinical drugs are based on microbial natural products, with compound classes including polyketides (PKS), non-ribosomal peptides (NRPS), fluoroquinones and ribosomally synthesized and post-translationally modified peptides (RiPPs). While variants of biosynthetic gene clusters (BGCs) for known classes of natural products are easy to identify in genome sequences, BGCs for new compound classes escape attention. In particular, evidence is accumulating that for RiPPs, subclasses known thus far may only represent the tip of an iceberg. Here, we present decRiPPter (Data-driven Exploratory Class-independent RiPP TrackER), a RiPP genome mining algorithm aimed at the discovery of novel RiPP classes. DecRiPPter combines a Support Vector Machine (SVM) that identifies candidate RiPP precursors with pan-genomic analyses to identify which of these are encoded within operon-like structures that are part of the accessory genome of a genus. Subsequently, it prioritizes such regions based on the presence of new enzymology and based on patterns of gene cluster and precursor peptide conservation across species. We then applied decRiPPter to mine 1,295 Streptomyces genomes, which led to the identification of 42 new candidate RiPP families that could not be found by existing programs. One of these was studied further and elucidated as a novel subfamily of lanthipeptides, designated Class V. Two previously unidentified modifying enzymes are proposed to create the hallmark lanthionine bridges. Taken together, our work highlights how novel natural product families can be discovered by methods going beyond sequence similarity searches to integrate multiple pathway discovery criteria. Code and data availability: The source code of DecRiPPter is freely available online at https://github.com/Alexamk/decRiPPter . Results of the data analysis are available online at http://www.bioinformatics.nl/~medem005/decRiPPter_strict/index.html and http://www.bioinformatics.nl/~medem005/decRiPPter_mild/index.html (for the strict and mild filters, respectively). All training data and code used to generate these, as well as outputs of the data analyses, are available on Zenodo at doi:10.5281/zenodo.3834818 .Keywords
All Related Versions
- Published version: PLOS Biology, 18 (12), e3001026.
This publication has 76 references indexed in Scilit:
- Polyphasic classification of the gifted natural product producer Streptomyces roseifaciens sp. nov.International Journal of Systematic and Evolutionary Microbiology, 2019
- Taxonomy, Physiology, and Natural Products of ActinobacteriaMicrobiology and Molecular Biology Reviews, 2016
- Goodbye to brute force in antibiotic discovery?Nature Microbiology, 2016
- Discovery of microbial natural products by activation of silent biosynthetic gene clustersNature Reviews Microbiology, 2015
- Platforms for antibiotic discoveryNature Reviews Drug Discovery, 2013
- Thoughts and facts about antibiotics: Where we are now and where we are headingThe Journal of Antibiotics, 2012
- Fix the antibiotics pipelineNature, 2011
- Origins and Evolution of Antibiotic ResistanceMicrobiology and Molecular Biology Reviews, 2010
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006
- Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)Nature, 2002